🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Agilent shares target cut by TD Cowen amid lowered F24 guide

EditorEmilio Ghigini
Published 05/30/2024, 09:50 PM
A
-

On Thursday, TD Cowen adjusted its outlook on Agilent Technologies, Inc. (NYSE:A) shares, lowering the price target from $163.00 to $153.00 while maintaining a Buy rating on the stock. The revision follows Agilent's post-market announcement, which saw the company's stock decline by 14%.

The firm's management has significantly reduced the fiscal 2024 guidance, projecting approximately a 5% decrease in organic growth and a 5% reduction in earnings per share (EPS), suggesting a more considerable cut to the second half of the fiscal year forecast.

The reduction in guidance was attributed to several factors, including a challenging market in China, a slower uptake in biopharma instruments, and a shortfall in the NASDAQ index.

Despite the lowered expectations and current market uncertainties, the analyst believes that the revised forecast has accounted for these risks.

The analyst's commentary highlighted that while market visibility remains low, the new guidance appears to be conservative.

They suggest that Agilent's current valuation, particularly after the drop in share price, may present a roughly 20% upside potential for investors over the next 12 months.

Agilent Technologies, a leader in life sciences, diagnostics, and applied chemical markets, has been navigating a complex global environment.

The company's performance is closely watched by investors as it serves as a bellwether for the broader scientific and healthcare instrument sector.

Despite the recent adjustments, TD Cowen's continued Buy rating indicates a belief in Agilent's long-term value proposition and potential for recovery as market conditions evolve.

The firm's analysis points to an anticipated return on investment, considering the stock's current trajectory and market position.

InvestingPro Insights

Following the recent adjustments in Agilent Technologies, Inc.'s (NYSE:A) outlook, current InvestingPro data reveals a market capitalization of $38.21 billion, reinforcing the company's substantial presence in the life sciences and diagnostics sector. With a P/E ratio of 34.48, Agilent is trading at a higher earnings multiple, which may suggest optimism about the company's future growth despite the recent dip in share price. Additionally, the company's dividend yield stands at 0.65%, demonstrating a commitment to shareholder returns, having maintained dividend payments for 13 consecutive years – a testament to its financial resilience.

An InvestingPro Tip worth noting is that Agilent's stock generally trades with low price volatility, which could be a reassuring factor for investors looking for stability in their portfolio, especially in the current market environment. Moreover, the company's liquid assets exceed short-term obligations, providing a buffer in uncertain times. For those interested in further analysis and metrics, InvestingPro offers additional insights, including a total of 14 InvestingPro Tips for Agilent Technologies, which can be accessed with a special offer using coupon code PRONEWS24 for an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.